Tyrosine kinase inhibitors may boost cardiac risk in chronic myeloid leukemia
13/06/2016 - 22:00
Tyrosine kinase inhibitors were associated with a significantly increased risk of cardiovascular events among chronic myeloid leukemia patients.... More »
